The poll, conducted Sept. 19 to 21, asked participants what they were most concerned about in oncology right now. Of 834 respondents, 27 percent said health disparities, 26 percent said inadequate treatment options, 24 percent said cancer drug shortages and 22 percent said increased cases.
Some participants also pointed to issues such as cost of care and survivorship care and support.
Pathologist Michael Mazzotta, PhD, added in the comments, “During COVID-19, many people did not go for their routine annual checkup. Issues (like cancer) that could have been detected in 2020 are only now coming to light. I cannot speak for my colleagues, but the cancer just seems ‘uglier’ than normal and being discovered in much younger patients.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
